Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP1LC3B | Q9GZQ8 | 3/20 | 0.63 |
| ▸ | RAF1 | P04049 | 10/20 | 0.52 |
| ▸ | LRRK2 | Q5S007 | 5/20 | 0.52 |
| ▸ | PLK4 | O00444 | 2/20 | 0.52 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.52 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.52 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.52 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.52 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.52 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.52 |
| ▸ | EGFR | P00533 | 1/20 | 0.52 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.52 |
| ▸ | ARAF | P10398 | 1/20 | 0.52 |
| ▸ | PIM1 | P11309 | 1/20 | 0.52 |
| ▸ | BRAF | P15056 | 1/20 | 0.52 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.52 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.52 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.52 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.52 |
| ▸ | MYOC | Q99972 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7136800 | 0.95 | MAP1LC3B (0.56) | MAP1LC3BRAF1LRRK2PLK4PSEN1 | |
| SCHEMBL5363090 | 0.86 | LRRK2 (0.60) | MAP1LC3BRAF1LRRK2PLK4PSEN1 | |
| SCHEMBL5360968 | 0.86 | EGFR (0.54) | MAP1LC3BRAF1LRRK2PLK4PSEN1 | |
| SCHEMBL7137544 | 0.86 | LRRK2 (0.49) | MAP1LC3BRAF1LRRK2PLK4PSEN1 | |
| SCHEMBL5364049 | 0.83 | ERBB2 (0.59) | MAP1LC3BRAF1LRRK2PLK4PSEN1 | |
| SCHEMBL5369299 | 0.83 | EGFR (0.59) | MAP1LC3BRAF1LRRK2PLK4PSEN1 | |
| SCHEMBL5366852 | 0.83 | LRRK2 (0.50) | MAP1LC3BRAF1LRRK2PLK4PSEN1 | |
| SCHEMBL7131324 | 0.81 | MAP1LC3B (0.52) | MAP1LC3BRAF1LRRK2PLK4PSEN1 | |
| SCHEMBL7138253 | 0.81 | KDM1A (0.54) | LRRK2PLK4PIM1MEN1MAPT | |
| SCHEMBL7139913 | 0.81 | RAF1 (0.42) | MAP1LC3BRAF1LRRK2PLK4PSEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7202265-B2 | Indolinone combinatorial libraries and related products and methods for the treatment of disease | SUGEN, INC. (US) | 2007-04-10 | — | — | US | disclosed |
| US-20050197382-A1 | Indolinone combinatorial libraries and related products and methods for the treatment of disease | SUGEN, INC. | 2005-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050197382-A1 | Indolinone combinatorial libraries and related products and methods for the treatment of disease | FRK, PTK2, DSTYK | MAP1LC3B 1427/4885RAF1 245/4885LRRK2 289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.